featured
Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Randomized Phase III Trial of Pegvorhyaluronidase Alfa With Nab-Paclitaxel Plus Gemcitabine for Patients With Hyaluronan-High Metastatic Pancreatic Adenocarcinoma
J. Clin. Oncol 2020 Jul 24;[EPub Ahead of Print], E Van Cutsem, MA Tempero, D Sigal, DY Oh, N Fazio, T Macarulla, E Hitre, P Hammel, AE Hendifar, SE Bates, CP Li, SR Hingorani, C de la Fouchardiere, A Kasi, V Heinemann, A Maraveyas, N Bahary, L Layos, V Sahai, L Zheng, J Lacy, JO Park, F Portales, P Oberstein, W Wu, D Chondros, AJ BullockFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.